Choosing between immunity and tolerance after transplantation

Cellular Immunology

Volumn 248, Issue 1, 2007, Pages 44-47

  Samstein, Benjamin ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Complement; Immunity; Immunosuppression; Infection; Innate immunity; Interferon; Regulatory T cells; Tolerance; Toll like receptors

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN; STAT1 PROTEIN;

ANTIGEN SPECIFICITY; ARTICLE; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; EFFECTOR CELL; EX VIVO STUDY; GENETIC MANIPULATION; GRAFT REJECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOCYTE DEPLETION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; TRANSPLANTATION;

HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; IMMUNOCOMPETENCE; IMMUNOSUPPRESSION; ORGAN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 36048953443     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.06.009     Document Type: Article

References (56)

1. Pelletier R.P., et al. High incidence of donor-reactive delayed-type hypersensitivity reactivity in transplant patients. American Journal of Transplantation 2 10 (2002) 926-933
2. D.J. Cohen, L.S.M., L.L. Christensen, R.D. Bloom, R.S. Sung, Kidney and Pancreas Transplantation in the United States, 1995-2004. American Journal of Transplantation, 6(5p2) (2006) 1153-1169.
3. Hardinger K.L., et al. Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation. Transplantation 78 1 (2004) 136-141
4. Tan H.P., et al. Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. American Journal of Transplantation 6 10 (2006) 2409-2417
5. Roussey-Kesler G., et al. Clinical operational tolerance after kidney transplantation. American Journal of Transplantation 6 4 (2006) 736-746
6. Lerut J., and Sanchez-Fueyo A. An appraisal of tolerance in liver transplantation. American Journal of Transplantation 6 8 (2006) 1774-1780
7. Fudaba Y., et al. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. American Journal of Transplantation 6 9 (2006) 2121-2133
8. Dharnidharka V.R., Stablein D.M., and Harmon W.E. Post-transplant infections now exceed acute rejection as cause for hospitalization: A report of the NAPRTCS. American Journal of Transplantation 4 3 (2004) 384-389
9. Abbott K.C., et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transplant Infectious Disease 3 4 (2001) 203-211
10. Dharnidharka V.R., et al. Infection frequency and profile in different age groups of kidney transplant recipients. Transplantation 81 12 (2006) 1662-1667
11. Montoya J.G., et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center [see comment]. Clinical Infectious Diseases 33 5 (2001) 629-640
12. Abbott K.C., et al. Hospitalizations for bacterial septicemia after renal transplantation in the United States. American Journal of Nephrology 21 2 (2001) 120-127
13. C.H. Chen, J.L., C.H. Cheng, M.J. Wu, WC Lee, K.H. Shu, Mycobacterium tuberculosis infection following renal transplantation in Taiwan, Transplant Infectious Disease 8(3) (2006) 148-156.
14. Huzly D., et al. Routine immunizations in adult renal transplant recipients. Transplantation 63 6 (1997) 839-845
15. A. Kutinova, R.S.W., J.F. Ricci, D.C. Brennan, The incidence and costs of sepsis and pneumonia before and after renal transplantation in the United States, American Journal of Transplantation 6(1) (2006) 129-139.
16. Rabkin J.M., et al. Late mortality after orthotopic liver transplantation. American Journal of Surgery 181 5 (2001) 475-479
17. Ogle B.M., et al. Effacing of the T cell compartment by cardiac transplantation in infancy. Journal of Immunology 176 3 (2006) 1962-1967
18. Abbott K.C., et al. Late urinary tract infection after renal transplantation in the United States. American Journal of Kidney Diseases 44 2 (2004) 353-362
19. Ballet C., et al. Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft. American Journal of Transplantation 6 11 (2006) 2796-2801
20. Bayer A.L., et al. Essential role for interleukin-2 for CD4 + CD25+ T regulatory cell development during the neonatal period. Journal of Experimental Medicine 201 5 (2005) 769-777
21. Smith C.R., et al. Brief cyclosporine treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model. Transplantation 69 2 (2000) 294-299
22. Ring G.H., et al. Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts. Transplantation 67 10 (1999) 1362-1365
23. Mele T.S., et al. IFN-[γ] is an absolute requirement for spontaneous acceptance of liver allografts. American Journal of Transplantation 3 8 (2003) 942-951
24. H.D. Wang, M.E. Deng, S. Khandaker, M.H. Pickering, J.G. Chow, L.H. Garcia, B. Kelvin, D.J. Zhong, The axis of interleukin 12 and gamma interferon regulates acute vascular xenogeneic rejection. Nature Medicine, 6(5) (2000) 549-555.
25. Cordoba S.P., et al. Gene array analysis of a rat model of liver transplant tolerance identifies increased complement C3 and the STAT-1/IRF-1 pathway during tolerance induction. Liver Transplantation 12 4 (2006) 636-643
26. Fujino M., et al. Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted rats. Liver Transplantation 10 3 (2004) 379-391
27. Stepkowski S.M., et al. Janus tyrosine kinases and signal transducers and activators of transcription regulate critical functions of T cells in allograft rejection and transplantation tolerance. Transplantation 82 3 (2006) 295-303
28. Zhang Y., et al. Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells. Journal of Immunology 176 1 (2006) 128-137
29. Snow J.W., et al. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. Journal of Immunology 171 10 (2003) 5042-5050
30. Billiard F., et al. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. Journal of Immunology 177 4 (2006) 2167-2174
31. Toda A., and Piccirillo C.A. Development and function of naturally occurring CD4 + CD25+ regulatory T cells. Journal of Leukocyte Biology 80 3 (2006) 458-470
32. H. Wang, Z.L., Z. Sun, L. Sun, B. Zhang, Y. Zhao, A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice, Transplantation, 82(11) (2006) 1484-1492.
33. Boros P., et al. New cellular and molecular immune pathways in ischemia/reperfusion injury. American Journal of Transplantation 6 4 (2006) 652-658
34. Carroll M.C., and Carroll M.C. The complement system in regulation of adaptive immunity. Nature Immunology 5 10 (2004) 981-986
35. Kemper C., et al. Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 421 6921 (2003) 388-392
36. Pratt J.R., et al. Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. American Journal of Pathology 163 4 (2003) 1457-1465
37. Brown K.M., et al. Influence of donor C3 allotype on late renal-transplantation outcome. New England Journal of Medicine 354 19 (2006) 2014-2023
38. Sohn J.H., et al. Tolerance is dependent on complement C3 fragment iC3b binding to antigen-presenting cells. Nature Medicine 9 2 (2003) 206-212
39. Lorenz E., et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infection & Immunity 68 11 (2000) 6398-6401
40. Arbour N.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nature Genetics 25 2 (2000) 187-191
41. Goldstein D.R., et al. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. Journal of Clinical Investigation 111 10 (2003) 1571-1578
42. Fekete A., et al. Association between heat shock protein 70s and Toll-like receptor polymorphisms with long-term renal allograft survival. Transplant International 19 3 (2006) 190-196
43. Ducloux D., et al. Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney International 67 6 (2005) 2454-2461
44. Samstein B., et al. Toll-like receptor-4 and allograft responses. Transplantation 77 3 (2004) 475-477
45. Tesar B.M., et al. TH1 Immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a Toll-like receptor signal adaptor protein. American Journal of Transplantation 4 9 (2004) 1429-1439
46. Sutmuller R.P.M., et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. Journal of Immunology 116 2 (2006) 485-494
47. Caramalho I., et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. Journal of Experimental Medicine 197 4 (2003) 403-411
48. Peng G., et al. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309 5739 (2005) 1380-1384
49. Chen L., et al. TLR engagement prevents transplantation tolerance. American Journal of Transplantation 6 10 (2006) 2282-2291
50. Brunn G.J., et al. Conditional signaling by Toll-like receptor 4. FASEB Journal 19 7 (2005) 872-874
51. C.E. Sharrock, M.S. Wanachiwanawin, W. Batchelor Jr., Analysis of the alloreactive T cell repertoire in man. I. Differences in precursor frequency for cytotoxic T cell responses against allogeneic MHC molecules in unrelated individuals, Transplantation (1987) 43.
52. Wu Z., et al. Homeostatic proliferation is a barrier to transplantation tolerance [see comment]. Nature Medicine 10 1 (2004) 87-92
53. Judge T.A., et al. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival. Journal of Immunology 162 4 (1999) 1947-1951
54. Markees T.G., et al. Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 64 2 (1997) 329-335
55. Yamazaki S., et al. Dendritic cells expand antigen-specific Foxp3+CD25+CD4+ regulatory T cells including suppressors of alloreactivity. Immunological Reviews 212 1 (2006) 314-329
56. Jiang S., et al. Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 102 6 (2003) 2180-2186